<?xml version="1.0" encoding="utf-8" ?> <rss version="2.0" xmlns:opensearch="http://a9.com/-/spec/opensearch/1.1/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom"> <channel> <title> <![CDATA[Cairo University Libraries portal Search for 'au:&quot;Abeer Ahmed Bahnassy.&quot;'with limit(s): 'suppress:false']]> </title> <!-- prettier-ignore-start --> <link> https://lis.cl.cu.edu.eg/cgi-bin/koha/opac-search.pl?idx=&#38;q=au%3A%22Abeer%20Ahmed%20Bahnassy.%22&#38;sort_by=relevance&#38;format=rss </link> <!-- prettier-ignore-end --> <atom:link rel="self" type="application/rss+xml" href="https://lis.cl.cu.edu.eg/cgi-bin/koha/opac-search.pl?idx=&#38;q=au%3A%22Abeer%20Ahmed%20Bahnassy.%22&#38;sort_by=relevance&#38;format=rss" /> <description> Search results for 'au:&quot;Abeer Ahmed Bahnassy.&quot;'with limit(s): 'suppress:false' at Cairo University Libraries portal </description> <opensearch:totalResults>13</opensearch:totalResults> <opensearch:startIndex>0</opensearch:startIndex> <opensearch:itemsPerPage>50</opensearch:itemsPerPage> <atom:link rel="search" type="application/opensearchdescription+xml" href="https://lis.cl.cu.edu.eg/cgi-bin/koha/opac-search.pl?idx=&#38;q=au%3A%22Abeer%20Ahmed%20Bahnassy.%22&#38;sort_by=relevance&#38;format=opensearchdescription" /> <opensearch:Query role="request" searchTerms="idx%3D%26q%3Dau%253A%2522Abeer%2520Ahmed%2520Bahnassy.%2522suppress%3Afalse" startPage="" /> <item> <title> Measurement of infiltrated CD₄+ / CD ₈+ ratio and cyclin D1 level and ploidy status and S - phase fraction in colorectal cancer patients / </title> <dc:identifier>ردمك: </dc:identifier> <!-- prettier-ignore-start --> <link>https://lis.cl.cu.edu.eg/cgi-bin/koha/opac-detail.pl?biblionumber=34699</link> <!-- prettier-ignore-end --> <description> <p> .<br /> 106 P. : 25cm.<br /> </p> <p> <a href="https://lis.cl.cu.edu.eg/cgi-bin/koha/opac-reserve.pl?biblionumber=34699">Place hold on <em>Measurement of infiltrated CD₄+ / CD ₈+ ratio and cyclin D1 level and ploidy status and S - phase fraction in colorectal cancer patients / </em></a> </p> </description> <guid>https://lis.cl.cu.edu.eg/cgi-bin/koha/opac-detail.pl?biblionumber=34699</guid> </item> <item> <title> Relation between BRCA-IRIS expression in metastatic breast cancer and different clinico-pathological factors / </title> <dc:identifier>ردمك: </dc:identifier> <!-- prettier-ignore-start --> <link>https://lis.cl.cu.edu.eg/cgi-bin/koha/opac-detail.pl?biblionumber=56237</link> <!-- prettier-ignore-end --> <description> <p> .<br /> 113 P. : 25cm.<br /> </p> <p> <a href="https://lis.cl.cu.edu.eg/cgi-bin/koha/opac-reserve.pl?biblionumber=56237">Place hold on <em>Relation between BRCA-IRIS expression in metastatic breast cancer and different clinico-pathological factors / </em></a> </p> </description> <guid>https://lis.cl.cu.edu.eg/cgi-bin/koha/opac-detail.pl?biblionumber=56237</guid> </item> <item> <title> Prognostic effect of drug resistance of glutathione - S - transferase in non small lung Cancer / </title> <dc:identifier>ردمك: </dc:identifier> <!-- prettier-ignore-start --> <link>https://lis.cl.cu.edu.eg/cgi-bin/koha/opac-detail.pl?biblionumber=39541</link> <!-- prettier-ignore-end --> <description> <p> .<br /> 167P. : 25cm.<br /> </p> <p> <a href="https://lis.cl.cu.edu.eg/cgi-bin/koha/opac-reserve.pl?biblionumber=39541">Place hold on <em>Prognostic effect of drug resistance of glutathione - S - transferase in non small lung Cancer / </em></a> </p> </description> <guid>https://lis.cl.cu.edu.eg/cgi-bin/koha/opac-detail.pl?biblionumber=39541</guid> </item> <item> <title> The prognostic value of MSI, c-kit and lymph node microscopic metastases in stage II colorectal cancer / </title> <dc:identifier>ردمك: </dc:identifier> <!-- prettier-ignore-start --> <link>https://lis.cl.cu.edu.eg/cgi-bin/koha/opac-detail.pl?biblionumber=62139</link> <!-- prettier-ignore-end --> <description> <p> .<br /> 78 P. : 25cm.<br /> </p> <p> <a href="https://lis.cl.cu.edu.eg/cgi-bin/koha/opac-reserve.pl?biblionumber=62139">Place hold on <em>The prognostic value of MSI, c-kit and lymph node microscopic metastases in stage II colorectal cancer / </em></a> </p> </description> <guid>https://lis.cl.cu.edu.eg/cgi-bin/koha/opac-detail.pl?biblionumber=62139</guid> </item> <item> <title> The predictive value of ERCC1, RRM1 and TS for MPM patients in National cancer institute, Cairo University / </title> <dc:identifier>ردمك: </dc:identifier> <!-- prettier-ignore-start --> <link>https://lis.cl.cu.edu.eg/cgi-bin/koha/opac-detail.pl?biblionumber=82758</link> <!-- prettier-ignore-end --> <description> <p> .<br /> 94 P. : 25cm .<br /> </p> <p> <a href="https://lis.cl.cu.edu.eg/cgi-bin/koha/opac-reserve.pl?biblionumber=82758">Place hold on <em>The predictive value of ERCC1, RRM1 and TS for MPM patients in National cancer institute, Cairo University / </em></a> </p> </description> <guid>https://lis.cl.cu.edu.eg/cgi-bin/koha/opac-detail.pl?biblionumber=82758</guid> </item> <item> <title> Flow cytometric immunophenotyping and detection of bcl - 6 gene rearrangement in egyptian b - cell lymphoma patients / </title> <dc:identifier>ردمك: </dc:identifier> <!-- prettier-ignore-start --> <link>https://lis.cl.cu.edu.eg/cgi-bin/koha/opac-detail.pl?biblionumber=36400</link> <!-- prettier-ignore-end --> <description> <p> .<br /> 240P : 25cm.<br /> </p> <p> <a href="https://lis.cl.cu.edu.eg/cgi-bin/koha/opac-reserve.pl?biblionumber=36400">Place hold on <em>Flow cytometric immunophenotyping and detection of bcl - 6 gene rearrangement in egyptian b - cell lymphoma patients / </em></a> </p> </description> <guid>https://lis.cl.cu.edu.eg/cgi-bin/koha/opac-detail.pl?biblionumber=36400</guid> </item> <item> <title> UGT1A1 assessment in cancer patient receiving irinotecan based chemotherapy / </title> <dc:identifier>ردمك: </dc:identifier> <!-- prettier-ignore-start --> <link>https://lis.cl.cu.edu.eg/cgi-bin/koha/opac-detail.pl?biblionumber=58451</link> <!-- prettier-ignore-end --> <description> <p> .<br /> 62 P. ; 25cm.<br /> </p> <p> <a href="https://lis.cl.cu.edu.eg/cgi-bin/koha/opac-reserve.pl?biblionumber=58451">Place hold on <em>UGT1A1 assessment in cancer patient receiving irinotecan based chemotherapy / </em></a> </p> </description> <guid>https://lis.cl.cu.edu.eg/cgi-bin/koha/opac-detail.pl?biblionumber=58451</guid> </item> <item> <title> Assessment of the trans-differentiation potential of bone marrow and umbilical cord blood stem cells in generating insulin producing cells / </title> <dc:identifier>ردمك: </dc:identifier> <!-- prettier-ignore-start --> <link>https://lis.cl.cu.edu.eg/cgi-bin/koha/opac-detail.pl?biblionumber=64220</link> <!-- prettier-ignore-end --> <description> <p> .<br /> 137 P. : 25cm.<br /> </p> <p> <a href="https://lis.cl.cu.edu.eg/cgi-bin/koha/opac-reserve.pl?biblionumber=64220">Place hold on <em>Assessment of the trans-differentiation potential of bone marrow and umbilical cord blood stem cells in generating insulin producing cells / </em></a> </p> </description> <guid>https://lis.cl.cu.edu.eg/cgi-bin/koha/opac-detail.pl?biblionumber=64220</guid> </item> <item> <title> Clinical correlation between programmed cell death ligand one expression, tumor infiltrating lymphocytes and pathological response of locally advanced breast cancer patients undergoing neoadjuvant therapy / </title> <dc:identifier>ردمك: </dc:identifier> <!-- prettier-ignore-start --> <link>https://lis.cl.cu.edu.eg/cgi-bin/koha/opac-detail.pl?biblionumber=79038</link> <!-- prettier-ignore-end --> <description> <p> .<br /> 129 P. : 25cm .<br /> </p> <p> <a href="https://lis.cl.cu.edu.eg/cgi-bin/koha/opac-reserve.pl?biblionumber=79038">Place hold on <em>Clinical correlation between programmed cell death ligand one expression, tumor infiltrating lymphocytes and pathological response of locally advanced breast cancer patients undergoing neoadjuvant therapy / </em></a> </p> </description> <guid>https://lis.cl.cu.edu.eg/cgi-bin/koha/opac-detail.pl?biblionumber=79038</guid> </item> <item> <title> Prospects for human stem cell therapy in the treatment of end stage liver cirrhosis in rats / </title> <dc:identifier>ردمك: </dc:identifier> <!-- prettier-ignore-start --> <link>https://lis.cl.cu.edu.eg/cgi-bin/koha/opac-detail.pl?biblionumber=163753</link> <!-- prettier-ignore-end --> <description> <p> 2022 .<br /> 124 p. : 25cm+.<br /> </p> <p> <a href="https://lis.cl.cu.edu.eg/cgi-bin/koha/opac-reserve.pl?biblionumber=163753">Place hold on <em>Prospects for human stem cell therapy in the treatment of end stage liver cirrhosis in rats /</em></a> </p> </description> <guid>https://lis.cl.cu.edu.eg/cgi-bin/koha/opac-detail.pl?biblionumber=163753</guid> </item> <item> <title> Dose dense CHOEP 14 regimen as first line treatment of young poor risk DLCL / </title> <dc:identifier>ردمك: </dc:identifier> <!-- prettier-ignore-start --> <link>https://lis.cl.cu.edu.eg/cgi-bin/koha/opac-detail.pl?biblionumber=40136</link> <!-- prettier-ignore-end --> <description> <p> .<br /> 189P. : 25cm.<br /> </p> <p> <a href="https://lis.cl.cu.edu.eg/cgi-bin/koha/opac-reserve.pl?biblionumber=40136">Place hold on <em>Dose dense CHOEP 14 regimen as first line treatment of young poor risk DLCL / </em></a> </p> </description> <guid>https://lis.cl.cu.edu.eg/cgi-bin/koha/opac-detail.pl?biblionumber=40136</guid> </item> <item> <title> Evaluation of vascular endothelial growth factor, insulin like growth factor receptor and transforming growth factor - Ý as prognostic factors in triple negative breast cancer patients / </title> <dc:identifier>ردمك: </dc:identifier> <!-- prettier-ignore-start --> <link>https://lis.cl.cu.edu.eg/cgi-bin/koha/opac-detail.pl?biblionumber=56199</link> <!-- prettier-ignore-end --> <description> <p> .<br /> 185 P. : 25cm.<br /> </p> <p> <a href="https://lis.cl.cu.edu.eg/cgi-bin/koha/opac-reserve.pl?biblionumber=56199">Place hold on <em>Evaluation of vascular endothelial growth factor, insulin like growth factor receptor and transforming growth factor - Ý as prognostic factors in triple negative breast cancer patients / </em></a> </p> </description> <guid>https://lis.cl.cu.edu.eg/cgi-bin/koha/opac-detail.pl?biblionumber=56199</guid> </item> <item> <title> Exicision repair cross-complementation group 1 (ERCC1) in platinum-based treatment of non-small cell lung cancer / </title> <dc:identifier>ردمك: </dc:identifier> <!-- prettier-ignore-start --> <link>https://lis.cl.cu.edu.eg/cgi-bin/koha/opac-detail.pl?biblionumber=38085</link> <!-- prettier-ignore-end --> <description> <p> .<br /> 213 P. : 25cm.<br /> </p> <p> <a href="https://lis.cl.cu.edu.eg/cgi-bin/koha/opac-reserve.pl?biblionumber=38085">Place hold on <em>Exicision repair cross-complementation group 1 (ERCC1) in platinum-based treatment of non-small cell lung cancer / </em></a> </p> </description> <guid>https://lis.cl.cu.edu.eg/cgi-bin/koha/opac-detail.pl?biblionumber=38085</guid> </item> </channel> </rss>
